Prevention of nosocomial infections in neonatal intensive care units

Paolo Manzoni, Daniele De Luca, Mauro Stronati, Evelyne Jacqz-Aigrain, Giulia Ruffinazzi, Martina Luparia, Elena Tavella, Elena Boano, Elio Castagnola, Michael Mostert, Daniele Farina

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Neonatal sepsis causes a huge burden of morbidity and mortality and includes bloodstream, urine, cerebrospinal, peritoneal, and lung infections as well as infections starting from burns and wounds, or from any other usually sterile sites. It is associated with cytokine - and biomediator-induced disorders of respiratory, hemodynamic, and metabolic processes. Neonates in the neonatal intensive care unit feature many specific risk factors for bacterial and fungal sepsis. Loss of gut commensals such as Bifidobacteria and Lactobacilli spp., as occurs with prolonged antibiotic treatments, delayed enteral feeding, or nursing in incubators, translates into proliferation of pathogenic microflora and abnormal gut colonization. Prompt diagnosis and effective treatment do not protect septic neonates form the risk of late neurodevelopmental impairment in the survivors. Thus prevention of bacterial and fungal infection is crucial in these settings of unique patients. In this view, improving neonatal management is a key step, and this includes promotion of breast-feeding and hygiene measures, adoption of a cautious central venous catheter policy, enhancement of the enteric microbiota composition with the supplementation of probiotics, and medical stewardship concerning H2 blockers with restriction of their use. Additional measures may include the use of lactoferrin, fluconazole, and nystatin and specific measures to prevent ventilator associated pneumonia.

Original languageEnglish
Pages (from-to)81-88
Number of pages8
JournalAmerican Journal of Perinatology
Volume30
Issue number2
DOIs
Publication statusPublished - 2013

Fingerprint

Neonatal Intensive Care Units
Cross Infection
Newborn Infant
Nystatin
Ventilator-Associated Pneumonia
Incubators
Lactoferrin
Bifidobacterium
Central Venous Catheters
Mycoses
Fluconazole
Microbiota
Probiotics
Enteral Nutrition
Lactobacillus
Infection
Breast Feeding
Hygiene
Burns
Bacterial Infections

Keywords

  • candida
  • fluconazole
  • infection
  • lactoferrin
  • neonate
  • probiotics
  • sepsis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Manzoni, P., De Luca, D., Stronati, M., Jacqz-Aigrain, E., Ruffinazzi, G., Luparia, M., ... Farina, D. (2013). Prevention of nosocomial infections in neonatal intensive care units. American Journal of Perinatology, 30(2), 81-88. https://doi.org/10.1055/s-0032-1333131

Prevention of nosocomial infections in neonatal intensive care units. / Manzoni, Paolo; De Luca, Daniele; Stronati, Mauro; Jacqz-Aigrain, Evelyne; Ruffinazzi, Giulia; Luparia, Martina; Tavella, Elena; Boano, Elena; Castagnola, Elio; Mostert, Michael; Farina, Daniele.

In: American Journal of Perinatology, Vol. 30, No. 2, 2013, p. 81-88.

Research output: Contribution to journalArticle

Manzoni, P, De Luca, D, Stronati, M, Jacqz-Aigrain, E, Ruffinazzi, G, Luparia, M, Tavella, E, Boano, E, Castagnola, E, Mostert, M & Farina, D 2013, 'Prevention of nosocomial infections in neonatal intensive care units', American Journal of Perinatology, vol. 30, no. 2, pp. 81-88. https://doi.org/10.1055/s-0032-1333131
Manzoni, Paolo ; De Luca, Daniele ; Stronati, Mauro ; Jacqz-Aigrain, Evelyne ; Ruffinazzi, Giulia ; Luparia, Martina ; Tavella, Elena ; Boano, Elena ; Castagnola, Elio ; Mostert, Michael ; Farina, Daniele. / Prevention of nosocomial infections in neonatal intensive care units. In: American Journal of Perinatology. 2013 ; Vol. 30, No. 2. pp. 81-88.
@article{f041ae04cd614a29acecd27d001bab15,
title = "Prevention of nosocomial infections in neonatal intensive care units",
abstract = "Neonatal sepsis causes a huge burden of morbidity and mortality and includes bloodstream, urine, cerebrospinal, peritoneal, and lung infections as well as infections starting from burns and wounds, or from any other usually sterile sites. It is associated with cytokine - and biomediator-induced disorders of respiratory, hemodynamic, and metabolic processes. Neonates in the neonatal intensive care unit feature many specific risk factors for bacterial and fungal sepsis. Loss of gut commensals such as Bifidobacteria and Lactobacilli spp., as occurs with prolonged antibiotic treatments, delayed enteral feeding, or nursing in incubators, translates into proliferation of pathogenic microflora and abnormal gut colonization. Prompt diagnosis and effective treatment do not protect septic neonates form the risk of late neurodevelopmental impairment in the survivors. Thus prevention of bacterial and fungal infection is crucial in these settings of unique patients. In this view, improving neonatal management is a key step, and this includes promotion of breast-feeding and hygiene measures, adoption of a cautious central venous catheter policy, enhancement of the enteric microbiota composition with the supplementation of probiotics, and medical stewardship concerning H2 blockers with restriction of their use. Additional measures may include the use of lactoferrin, fluconazole, and nystatin and specific measures to prevent ventilator associated pneumonia.",
keywords = "candida, fluconazole, infection, lactoferrin, neonate, probiotics, sepsis",
author = "Paolo Manzoni and {De Luca}, Daniele and Mauro Stronati and Evelyne Jacqz-Aigrain and Giulia Ruffinazzi and Martina Luparia and Elena Tavella and Elena Boano and Elio Castagnola and Michael Mostert and Daniele Farina",
year = "2013",
doi = "10.1055/s-0032-1333131",
language = "English",
volume = "30",
pages = "81--88",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers, Inc.",
number = "2",

}

TY - JOUR

T1 - Prevention of nosocomial infections in neonatal intensive care units

AU - Manzoni, Paolo

AU - De Luca, Daniele

AU - Stronati, Mauro

AU - Jacqz-Aigrain, Evelyne

AU - Ruffinazzi, Giulia

AU - Luparia, Martina

AU - Tavella, Elena

AU - Boano, Elena

AU - Castagnola, Elio

AU - Mostert, Michael

AU - Farina, Daniele

PY - 2013

Y1 - 2013

N2 - Neonatal sepsis causes a huge burden of morbidity and mortality and includes bloodstream, urine, cerebrospinal, peritoneal, and lung infections as well as infections starting from burns and wounds, or from any other usually sterile sites. It is associated with cytokine - and biomediator-induced disorders of respiratory, hemodynamic, and metabolic processes. Neonates in the neonatal intensive care unit feature many specific risk factors for bacterial and fungal sepsis. Loss of gut commensals such as Bifidobacteria and Lactobacilli spp., as occurs with prolonged antibiotic treatments, delayed enteral feeding, or nursing in incubators, translates into proliferation of pathogenic microflora and abnormal gut colonization. Prompt diagnosis and effective treatment do not protect septic neonates form the risk of late neurodevelopmental impairment in the survivors. Thus prevention of bacterial and fungal infection is crucial in these settings of unique patients. In this view, improving neonatal management is a key step, and this includes promotion of breast-feeding and hygiene measures, adoption of a cautious central venous catheter policy, enhancement of the enteric microbiota composition with the supplementation of probiotics, and medical stewardship concerning H2 blockers with restriction of their use. Additional measures may include the use of lactoferrin, fluconazole, and nystatin and specific measures to prevent ventilator associated pneumonia.

AB - Neonatal sepsis causes a huge burden of morbidity and mortality and includes bloodstream, urine, cerebrospinal, peritoneal, and lung infections as well as infections starting from burns and wounds, or from any other usually sterile sites. It is associated with cytokine - and biomediator-induced disorders of respiratory, hemodynamic, and metabolic processes. Neonates in the neonatal intensive care unit feature many specific risk factors for bacterial and fungal sepsis. Loss of gut commensals such as Bifidobacteria and Lactobacilli spp., as occurs with prolonged antibiotic treatments, delayed enteral feeding, or nursing in incubators, translates into proliferation of pathogenic microflora and abnormal gut colonization. Prompt diagnosis and effective treatment do not protect septic neonates form the risk of late neurodevelopmental impairment in the survivors. Thus prevention of bacterial and fungal infection is crucial in these settings of unique patients. In this view, improving neonatal management is a key step, and this includes promotion of breast-feeding and hygiene measures, adoption of a cautious central venous catheter policy, enhancement of the enteric microbiota composition with the supplementation of probiotics, and medical stewardship concerning H2 blockers with restriction of their use. Additional measures may include the use of lactoferrin, fluconazole, and nystatin and specific measures to prevent ventilator associated pneumonia.

KW - candida

KW - fluconazole

KW - infection

KW - lactoferrin

KW - neonate

KW - probiotics

KW - sepsis

UR - http://www.scopus.com/inward/record.url?scp=84874108768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874108768&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1333131

DO - 10.1055/s-0032-1333131

M3 - Article

C2 - 23292914

AN - SCOPUS:84874108768

VL - 30

SP - 81

EP - 88

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 2

ER -